We are international
Donate
TEXT SIZE   


Dr. Kaufman - Lenalidomide, Bortezomib, and Dexamethasone (RVD) In Combination with Vorinostat as Front-Line Therapy for Patients with Multiple Myeloma (MM): Initial Results of a Phase 1 Study
Jonathan L. Kaufman
Winship Cancer Institute of Emory University
Atlanta, Georgia
USA
12.02.10


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles